Cationic antigens are known to have considerable arthritogenic potential in experimental systems. During a systematic search for suitable, naturally occurring candidates an intracellular protein was isolated from the ribosomal pellet of Yersinia enterocolitica 0:3, a bacterial strain associated with reactive arthritis in humans. The protein is highly cationic, contains two 19-kD polypeptide chains linked by a disulfide bond, and reveals a strong tendency for spontaneous aggregation. It is suggested to be a nucleic acid binding protein. We tested this antigen for its ability to induce arthritis after intra-articular challenge in preimmunized rats. An acute inflammatory phase followed by transition to chronicity was observed both by technetium-99m scintigraphy and from histology. Massive polymorphonuclear leucocyte infiltration of the synovium was seen early on and fibrosis and thickening of the joint capsule occurred in later stages. Control groups showed no evidence of inflammation. Western blot and ELISA analysis of unselected sera from Yersinia enterocolitica 0:3-infected patients revealed antibodies to the antigen in the majority of cases, whereas healthy individuals rarely reacted. This is the first report of a naturally occurring cationic antigen capable of inducing immunologic tissue injury; it justifies the speculation that cationic antigens from prokaryotic cells could trigger reactive arthritis.in humans. (J. Clin. Invest. 1991. 87:632-642.) 
Introduction
Reactive arthritis is a relatively common complication in individuals suffering from enteric infections with Yersinia enterocolitica (Y.e).' It develops typically 1-4 wk after onset ofenteritic symptoms and the clinical course varies between acute, selflimiting forms in the vast majority of cases, as well as intermittent relapsing and finally chronic forms in up to 10% of those affected (1) ; about 10% of patients with arthritis develop Reiter's syndrome.
Reactive arthritis is defined by its association with a recog-nized microbial infection; in the past there was a general consensus regarding the absence of viable microbes or microbial products in the affected joint. In the case of Yersinia enterocolitica this opinion has been substantially modified by the investigations of Toivanen, Lahesmaa-Rantala, Granfors, and coworkers in Finland. These workers could demonstrate the presence of Yersinia antigens in both immune complexes (2) and cells (3) from the synovial fluid of patients suffering from reactive arthritis, and moreover probably as deposits in the patient's synovium itself (4) . These findings are analogous to those of other investigators in Reiter's syndrome concerning deposition ofchlamydial antigens, chlamydial elementary bodies, and immunoglobulin in synovial tissue or their presence in synovial fluid (5) (6) (7) . On the basis of these observations in humans, one can propose an involvement of microbial antigens in the pathogenesis of this disease group. Antigen-induced arthritis has a sound experimental basis in animals. Chronic arthritis can be induced by intra-articular administration of antigens into preimmunized animals; this system was first described in rabbits (8, 9) and later in mice (10, 1 1) . Antigen retention by immune complex formation within collagenous tissues ofthejoint was proposed as the major mechanism for induction and maintenance ofthis disease in rabbits (12, 13) . In contrast, quite different conditions exist in mice. Native proteins like BSA, useful as an arthritogen in rabbits, lacked any arthritogenic potential in rodents. In further contrast to this, molecules rendered strongly cationic by chemical modification were recognized to be powerful arthritogens due to their electrostatic trapping by polyanionic joint structures ( 14).
Besides the influence of charge, size was shown to be another important determinant for arthritogenicity ofantigens in the mouse model (15, 16). Similar results were obtained in an analogous rat model (Gondolf et al., submitted for publication).
The purpose of the present work was to develop an animal model for human reactive (postinfectious) arthritis using cationic, native bacterial components as antigen and exploiting conclusions from earlier studies with artificially altered proteins. During the search for suitable candidates for arthritis induction we identified a cationic intracellular, putative nucleic-acid binding protein from Yersinia enterocolitica 0:3, which was a potent arthritogen in rats.
Methods Animals
Male Wistar rats (Zentraltierzuchterei Hannover, Hannover, FRG) were used throughout. The body weight was 100 g at the beginning of the experiments. Intra-articular injections were carried out under ether narcosis.
singstroke, Hants., England) at 30'C and pH 7.0 in a fermenter (Applikon, Schiedam, The Netherlands). 10% glucose solution was added at regular intervals. After reaching the stationary phase, cells were harvested by centrifugation (2,000 g, 15 min) (Sorvall model RC-5B, DuPont Co., Bad Hoburg, FRG) and the wet weight was estimated. The two cultures (50 g) were resuspended in 10 mM Tris-HCl, pH 8.0, HCl, pH 8.0, containing 100 mM MgCl2 and 1 mM PMSF (2 ml/g wet weight) and disrupted in a homogenizer (Braun, Melsungen, FRG) using glass beads with a diameter of 0.1-0.1 1 mm. After extensive washing in the above-mentioned buffer the glass beads were removed by sedimentation. Further procedures were carried out as described by Lathe and co-workers (17) with certain modifications. Briefly, the remaining supernatant was incubated at 370C for 1 h in the presence of DNAase I (Sigma Chemical Co., Deisenhofen, FRG) at a concentration of 10 ,ug/ml. Thereafter intact cells were removed by centrifugation (2,000 g, 20 min) and the supernatant was centrifuged twice at 37,000 g for 1 h (sediment called membrane pellet) and then at 150,000 g for 2 h (40C). The final sediment, the ribosomal pellet (l 50,000 g) was extracted with 66% acetic acid containing 33 The 1 50,000-g supernatant was recentrifuged to remove residual ribosomes and incubated at 100°C for 1 h. The precipitate was removed by centrifugation (10,000 g, 15 min), and 37% HCI was added to the supernatant to a final concentration of 0.25 N. Insoluble material was again removed by centrifugation and the soluble proteins were precipitated by adding 5 vol ofacetone. The proteins were resolubilized with 0.1 N HCI and stored at 4°C until examination.
The proteins of the membrane pellet (see above) were extracted with 0.25 N HCI under continuous stirring at 4°C overnight; insoluble material, including nucleic acids, was removed by ultracentrifugation (200,000 g for 2 h); and dialysis against PBS was performed as described above.
The extracted fraction ofthe ribosomal pellet contained the protein of interest (see Results) and was further separated either by repeated size-exclusion chromatography or by ion-exchange chromatography followed by size exclusion chromatography (see Results).
Size-exclusion chromatography
A Sephadex G-100-superfine column (Pharmacia, Freiburg, FRG) of 2.5 x 90 cm in PBS buffer at 40C was used. The column was calibrated for molecular mass estimation using horse spleen ferritin (480 kD, prepared according to Vogt et al. [ 18] ), BSA (68 kD, Behring, Marburg, FRG), streptococcal proteinase (30 kD, prepared according to Elliott and Liu [ 19] ), and lysozyme (14-kD, Sigma Chemical Co.). A constant flow rate of 10 ml/h was maintained and the eluate was monitored at 280 nm.
The column was then loaded with 10-25 mg ofthe protein fraction (crude ribosomal pellet extract; see above). Fractions of 6 ml were collected, and the main peaks were pooled and concentrated in an ultrafiltration cell (YM0 membrane, Amicon Corp., Witten, FRG), and analyzed by SDS-PAGE.
Ion-exchange chromatography
The whole procedure was performed using a fast protein liquid chromatography system (Pharmacia). After equilibration with 0.15 M NaCl in 10 mM phosphate, pH 7.4 (starting buffer), a Mono S-cation exchange column, HR 5/5 (Pharmacia), was loaded with 20 mg ofthe sample in starting buffer. Elution was performed with a sodium chloride gradient ranging from 0.15 to 2 M, followed by a single application (3 ml) of6 M guanidine, pH 7.4, with the flow rate 0.5 ml/min. l-ml fractions were collected and analyzed by SDS-PAGE before they were pooled.
Determination ofprotein concentration
The protein concentration was measured by bicinchoninic acid protein assay reagent (20) 
Isoelectric point determination
The isoelectric point (pl) was estimated by isoelectric focusing in polyacrylamide gels (T = 5.5%, C = 2.7%) containing 6% ampholyte (pH range 3.5-10; Pharmacia), using pl markers (pI range 3-10, Pharmacia).
Radioisotopic labeling ofproteins
Lysozyme, histone fl (22) and Yersinia antigen (see Results) were labeled with 1211 (Amersham, Branschweig, FRG) by the chloramine-T method (23 Human sera Samples of human sera were taken from patients with Y.e. caused enteric disease. The diagnosis was based on the presence ofraised agglutinin titers (> 1:80) to boiled and formalized antigens, together with isolation of Y.e. from the faeces, in all cases. A collective of49 patients was studied. Y.e. strains isolated were Y.e. serotypes 0:3 (n = 35), 0:9 (n = 3), 0:3 + 0:9 (n = 1), 0:6.30, (n = 1), biovar 1, (n = 4), biovar 3 (n = 3), biovar 2 (n = 1), and Y. frederiksenii (n = 1). The control collective (n = 31) consisted of sera taken from pregnant women during routine screening.
Western blot procedure
Yersinia antigen (see Results) was run on an SDS-PAGE gel (T = 15%, C = 2.7%) under mild reducing conditions (0.5% j3-mercaptoethanol; see Results). The proteins were electrotransferred (24) to Immobilon-P membranes (Millipore Corp., Bedford, MA). Membrane strips were incubated overnight with patient's sera diluted 1:100, followed by incubation with 1:5,000 diluted peroxidase-labeled goat anti-human IgG (Dianova, Hamburg, FRG) for 1 h. Finally, the strips were developed with diaminobenzidine (Sigma Chemical Co.).
ELISA
Antibody levels were measured using an ELISA system. Wells of flatbottomed microtiterplates (Greiner, Nflrtingen, FRG) were coated with 0.05 ,ug of Yersinia antigen (see Results) or BSA. Incubation with the chosen dilution of a serum sample and 1:5,000 diluted peroxidaselabeled goat anti-human (or rat) IgG was performed. After development the OD492,,, was measured in a Titertek Multiscan MMC (Flow Laboratories, Meckenheim, FRG).
Skin testing
Delayed-type hypersensitivity was measured 48 h after injection of 5 ,g of antigen in 5 1l PBS into the pinna of the ear. The contralateral ear, injected with PBS, served as control. Increase in ear thickness was measured with an engineer's micrometer.
Histology
Knee joints were detached and fixed in 4% buffered formalin, decalcified, and embedded in paraffin. Standard frontal sections of the joint were cut and stained with hematoxilin and eosin.
Technetium-99m uptake measurements Joint inflammation was determined by 99"Tc pertechnetate uptake measurements ofthe kneejoints; this method correlates well with histologic scores in arthritic joints (25, 26) . Each rat was injected with 2 MBq 9'Tc in 0.1 ml of PBS subcutaneously into the neck region; 30 min later the intensity of gamma radiation over both knee joints was measured by a collimated photoscintillation crystal (Berthold, Wildbad, FRG), keeping the knee joints in a defined position and carefully shielding the bodies ofthe rats. Inflammation was scored as the ratio of the 9'Tc uptake in the left vs. that of the right knee joint (L/R ratio).
Antigen retention in vivo 25 Mg of "25I-labeled samples were injected in 50 Ml of PBS into the left knee joint of rats; the right knee joint received PBS. At various days thereafter radioactivity was measured over both knees by external gamma counting, similar to the 99mTc uptake measurements (see above). Values from the left knee were corrected by deducting counts in the right knee, which resulted from blood contamination. Three groups ofnonimmune rats (n = 4), injected with either lysozyme, histone fl, or Yersinia antigen (see Results) were compared. The studies in nonimmune rats were performed to obtain data on the charge-mediated binding ofthree different polycationic molecules in vivo. Another group of rats (n = 4) immunized with Yersinia antigen was studied to examine the additional influence of antibody-mediated retention.
Immunization and intra-articular injection
Rats were immunized with 100 Mg of antigen, emulsified in complete Freund's adjuvant (total volume 300 Ml) by subcutaneous injection into the dorsal region, and boostered twice with the same dose at 2-wk intervals, until an adequate immune response was induced. Adjuvant was not injected into the hindleg region to avoid joint interference. Intra-articular injections were carried out using a 27-gauge needle inserted into the hindleg knee joint space; the standard injection volume was 50 Ml.
Arthritis induction
Four groups of immunized rats were challenged in the left knee joint with 50Mg ofthe appropriate antigen (see Table I and Results). In group 1 (arthritic), joint inflammation was determined by 9'9Tc uptake measurements at days 2, 6, 14, 24, 34, and 44; left and right knee joints from two rats were taken for histological examination at days 2, 6, 26, 40, and 78. In the control groups (2, 3) 9'Tc uptake was measured at days 2 and 10, and histological examination was performed on knee joints from two rats per group at day 6. Preparation of the tetrameric lysozyme used in group 2, as well as the control group 4, designed to show that polyanionic antigens are not arthritogenic in this system, has been reported in detail elsewhere (Gondolfet al., submitted for publication).
Tissue autoradiography
Dry decalcified, deparafinized tissue sections were covered by photographic emulsion (NTB 2, Eastman Kodak Co.), melted at 42°C for 30 min before use. The slides were dried for 1 h and then exposed for 14-28 d at 4°C. After exposure slides were processed in Kodak D19 developer for 150 s and the reaction was stopped by 2% acetic acid within 15 s, followed by fixation in Rapid Fix (Agfa Gevaert 1:8; Leverkusen). Finally, the slides were stained with hematoxilin and eosin.
Statistical analysis
Independent groups were compared by the t test.
Results

Characterization ofisolated Yersinia antigen
The ribosomal pellet derived from homogenized Y.e. 0:3 cells was composed of several proteins with a molecular mass ranging between 9 and 100 kD in SDS-PAGE; under reducing conditions, one strong band running at 19 kD (designated Y.e. 0:3 19 kD) was dominant. It eluted mainly in the major peak obtained from a first chromatography ofthe crude ribosomal pellet extract on a Sephadex G-100 superfine column (peak I in Fig. 1 ). Under nonreducing conditions a 38-kD band in SDS-PAGE appeared, which in fact could be converted into the 19-kD band by 5% mercaptoethanol ( Fig. 2 b) ; we appear to be dealing with a thiol-stabilized dimer. Using much lower concentrations of mercaptoethanol-(0.5%), both the 38-and the 19-kD forms were visible (these conditions were used in the Western blot procedure for testing patients' sera; see Fig. 3 ). The material found in peak I appears to represent the dimner protein complexed with other molecules. Further purification could be achieved by a second run of peak I under the same conditions, three main peaks resulted (Fig. 1) . Each peak contained the protein of interest (Y.e. 0:3 19 kD) in varying amounts, the highest quantity appeared in peak Ib (for protein content see also Fig. 2 a, lane 1) , whose elution volume was close to that ofBSA (68-kD), which indicates a degree ofaggregation. Peak Ia, the exclusion fraction, represents a highly ag- 634 Mertz et al. 19 -kD in highly purified form was present in a peak eluting with 0.3 M NaCl (probably representing the nonaggregated form), traces were also found throughout the whole salt gradient, together with other proteins (demonstrating a strong tendency for aggregation with other proteins). When the peak eluting with 6 M guanidine in ion-exchange chromatography was subsequently run on a Sephadex G-100 Superfine column, a profile similar to that ofthe second run shown in Fig. 1 was seen (not shown) .
By isoelectric focusing the 19-kD protein revealed a pl 2 9.3. Exact determination was not possible since the protein migrated into the cathodal strip (Fig. 2 c) . Only traces of the 19-kD protein could be found in the membrane fraction (37,000 g) (not shown), whereas in the 150,000 g supernatant the 19-kD protein was also present (not shown), but in quantities far lower than in the ribosomal pellet.
Prevalence ofthe 19-kD protein in other bacteria
The four other Y.e. (non 0:3) strains tested also contained the 1 9-kD protein, but in much lower amounts than seen in the 0:3
serovar. The other enterobacteria tested (E. coli, S. enteritides, S. sonnei, and C. jejuni) were all negative. (Fig. 1) 
Affinity for polyanionic structures in vitro
For these studies 1251-labeled preparations were used (see Fig. 2  d) ; the Y.e. 0:3 19-kD preparation used was aggregated and corresponded to fraction Ib (Fig. 1 ). 
Antigen retention in vivo
Retention data for I25I-labeled natural cationic proteins within the joints of nonimmune animals after intra-articular injection are shown in Fig. 6 a. Lysozyme disappeared most rapidly from the joint. The persistence of Y.e. 0:3 19 kD (aggregated; see fraction lb, Fig. 1 ) and histone fl was prolonged to a comparable extent. This is in accordance with the results of affinity studies to polyanionic matrices in vitro (see above and Figs. 4 and 5). In immune rats retention of Y.e. 0:3 19 kD showed a further significant increase (Fig. 6 b) . Distribution of Y.e. 0:3 19-kD in the joint Autoradiography was performed 6 h after injection of '25I-labeled Y.e. 0:3 19 kD and showed the antigen to be distributed in the synovial tissue as well as on the surface and in the deep layers of the cartilage (Fig. 7) .
Arthritis induction with Y.e. 0:3 19 kD Challenge with 50 ,ug ofY.e. 0:3 19 kD (aggregated; see fraction Ib, Fig. 1 ) into the left hindleg knee-joint of rats previously immunized with this antigen (group 1 in Table I ) produced chronic arthritis; this could still be observed 78 d after injection of the antigen (Fig. 8 d) . The histologic findings were noteworthy: in the acute phase (day 2) massive edema of the synovial lining, accompanied by a diffuse inflammatory infiltrate was seen (Fig. 8 a) . Neutrophilic granulocytes predominated, and some histiocytes and lymphocytes were also present. The surfaces of the joint structures were partially covered by a fibrin layer. The pannus at the juxtaposition of cartilage and synovial lining, in both the medial and lateral joint space, in severe cases (Fig. 8  b) . Destruction of the cartilage structures was beginning. The chronic stage was reached by day 26, when sclerosis with marked increase of fibroblasts could be observed within the joint capsule. Some patchy infiltrates consisting of lymphocytes were still present (Fig. 8 c) . At that time, mean values of the L/R ratio by 99"Tc-scintigraphy were 1.1 on average after a summit of 1.35 at day 2 (Fig. 9) . In more severe cases, the cartilage and synovial lining were also replaced by scar tissue. Moreover, a slight proliferation ofsynovial lining cells was visible. These tissue changes still persisted at day 78 (Fig. 8 d) . At the time of antigen challenge, the antibody response ofthe rats to the fraction used for immunization in this group (Tb, Fig. 1 ) was examined by Western blotting. All rats showed a very strong response to the 19-kD protein, although antibody to the other components of the aggregated antigen (fraction Tb) was virtually absent. In the control groups 2, 3, and 4 (Table I) , no inflammation could be observed either by 99mTc-scintigraphy (Fig. 9 ) or by histology (not shown).
In a further experiment three rats were immunized with Y.e. 0:3 19 kD and challenged with nonaggregated Y.e. 0:3 19-kD antigen (fraction Ic; see Fig. 1 ); only a very mild, transient inflammatory reaction was seen. This latter result is not reported in detail, but underlines the importance of antigen size, in this case the degree of aggregation, for arthritogenicity.
Human sera
The serologic relevance of the Y.e. 0:3 19-kD protein in patients suffering from yersiniosis could be shown using the Western blot and ELISA procedure. In Western blot, sera of the collective of patients (n = 35) with proven Y.e. 0:3 infections clearly reacted with the Y.e. 0:3 19-kD protein in almost all cases, preferentially with the dimer (38 kD); selected sera are shown in Fig. 3 . In contrast, sera of the control collective did not give a positive reaction in the majority of cases. Sera of patients infected with Yersinia serotypes other than 0:3 produced very faint bands at 38 kD in 50% of cases. For ELISA analysis, the OD492. of the control sera was measured at a defined dilution and the mean+3 SD was chosen as the cutoff point for a positive seroreaction in the patients; on this basis Figure 4 . Elution profile ofdifferent '25I-labeled cationic proteins (Fig.  1 d) The arthritis induced by the Y.e. 0:3 1 9-kD protein begins with an acute phase consisting of neutrophilic granulocyte infiltration of the synovium, together with edema and fibrin layer formation. This is followed by a subacute stage with formation of pannus and a chronic stage with massive sclerosis of the synovial lining, accompanied by an increase of synovial fibroblasts. Severe cases revealed spreading of inflammation to the cartilage, especially in juxtaposition to the inflamed synovium. These histopathological features closely resemble those seen in reactive arthritis in humans, where the clinical picture is also dominated by acute, patchy, nonspecific changes with infiltration by granulocytes combined with little or no synovial lining cell hyperplasia (1). In long-standing cases the experimental disease exhibits increasing resemblance to changes of rheumatoid disease, where the focus of cartilage and bone destruction occurs in juxtaposition to the inflamed synovium.
Antigen retention is an important determinant ofthe severity of injury in antigen-induced allergic arthritis and was given close attention in this study. When injected into the joint of nonimmune rats, the Y.e. 0:3 1 9-kD protein was retained significantly better than another cationic molecule, native lysozyme. The function of the Y.e. 0:3 19-kD protein may be in binding (stabilization) of nucleic acids. Several observations support this conclusion: firstly, a major portion of the protein appears in the ribosomal pellet, when the microbes are disrupted and the membranes are removed by repeated centrifugation (17) . Secondly, the protein has strong affinity for DNA-cellulose, which cannot be explained by a general nonspecific binding of DNA by cationic molecules, since lysozyme-also highly cationic (pI 11.3)-shows a markedly different elution behavior from DNA-cellulose matrix. In fact, the elution behavior of the Y.e. 0:3 19-kD protein was similar to that of histone fl, a well-studied DNA-packing protein in eukaryotic cells (31) . Furthermore, the protein was also seen in the 1 50,000-g supernatant after excess heating and strong acidification (results not reported here), a fraction, where Lathe and co-workers (17) presence of the microbe itself in joints was reported in Yersinia-triggered arthritis (40) . It is worth mentioning that immune complex formation in reactive arthritis in humans is a frequent feature, not only in the circulation (39) but more important within the joint (2).
In the early phase of Reiter's syndrome interesting findings were reported by several investigators: Schumacher et al. (5) were able to show, by immune electron microscopy, strongly positive peroxidase reaction products in vacuoles ofperivascular cells, which were highly suggestive of chlamydial elementary bodies. These authors also found fibrin and electron-dense granular material in the vessel walls, which could have been immune complexes. Additionally, Baldassare and co-workers (7) noted deposition of IgM, fibrin, and C3 around the vessels in the synovium by immunofluorescence in the majority of 12 patients with Reiter's syndrome. The latter findings are a focus of special interest, inasmuch as they indicate a possible way for initiation of the disease: the deposition of immunoglobulins around the vessels in the synovium could occur as an immune response to a previously bound antigen, which, for instance, could have been released from bacteria within the circulation. This view is supported by an experimental observation with the Y.e. 0:3 19-kD protein: on perfusion into the renal artery of rats, the protein showed strong affinity not only for the glomerular basement membrane, but also for the blood vessels in general (e.g., peritubular vessels) in a fine granular pattern by immunofluorescence; those deposits were accessible for circulating antibody (manuscript in preparation). This justifies the speculation that cationic Yersinia products (e.g., histone-like proteins), once released into the circulation, could accumulate within the vessel walls of the synovium, acting thereby as a target for immune complex formation and immune reactions in general.
The Serologic studies may well provide useful information as Granfors, Toivanen, and co-workers (41-43) found a more vigorous and prolonged serum-IgA and IgG anti-Yersinia antibody response in arthritic compared to nonarthritic patients. Elevated IgA levels indicate a continuous stimulation of the immune system by non-or ineffectively eliminated antigens or whole microbes; moreover, it has been speculated that the inability ofIgA antibodies to directly fix complement (44, 45) , in contrast to IgM and IgG, and their specific binding to antigenic sites might result in a blocking of phagocyte function and impair antigen elimination (46) .
Several ideas are currently being connected with the pathogenesis of reactive arthritis. A new concept of stress protein induced autoimmunity and rheumatoid arthritis (47) has claimed attention, since stress proteins are highly conserved during evolution and occur in many bacterial species (48) . This notion could also be helpful in explaining the induction of reactive arthritis by a variety of bacterial species. Another important observation in cases of reactive arthritis was the detection of a genetic component at the host level. The HLA-B27 antigen occurs in -75% of patients (1, 49), compared to < 10% in the normal population. Various hypotheses have been proposed to explain this connection, including the concept of molecular mimicry (50, 51) which concerns structural similarities between bacterial components and HLA-B27 antigen. To date partial sequence data did not reveal any homologies between HLA-B27 and Y.e. 0:3 19 kD.
Many questions remain open, but after paying due homage to the convincing immunological and histopathological findings in reactive arthritis cited above, we favor the "classic" concept of deposition of bacterial components or survival of bacteria itself within structures. The current work delineates a role for naturally occurring cationic antigens in the induction ofarthritis. We speculate further that nucleic acid binding proteins, especially histone-like proteins from prokaryotic cells could be involved in the pathogenesis of reactive arthritis.
